A potential pharmaceutical intervention for co-occurring PTSD and substance use disorder

(Medical University of South Carolina) Veterans with co-occurring PTSD and substance abuse disorder (SUD) who received the antioxidant N-acetylcysteine in addition to group cognitive behavioral therapy (CBT) for their SUD had fewer PTSD symptoms and less craving and depression than those who underwent CBT alone, according to the findings of a randomized, controlled pilot trial recently reported by researchers at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center in the Journal of Clinical Psychiatry.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news